Press Releases April 7, 2026 08:00 PM

Privia Health to Report First Quarter 2026 Results on Thursday, May 7

Privia Health announces Q1 2026 earnings release date and conference call

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
PRVA

Privia Health Group, Inc. will release its financial results for the first quarter ending March 31, 2026, on May 7, 2026, before market open. The company will also host a conference call to discuss the results and provide a future outlook.

Privia Health to Report First Quarter 2026 Results on Thursday, May 7
PRVA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Q1 2026 financial results to be released on May 7 before market open.
  • Privia Health operates a large network of 1,300+ physician practices and serves 5.8+ million patients across 24 states and DC.
  • Company focuses on technology-enabled healthcare delivery to improve outcomes and lower costs.

ARLINGTON, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2026 before market open on Thursday, May 7, 2026.

The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company’s Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 7, to discuss the results and management’s outlook for future financial and operational performance.

You can visit ir.priviahealth.com/news-and-events/events-and-presentations to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. To participate in the live conference call, dial 888-596-4144 (or 646-968-2525 for international callers) and provide Conference ID 5704885.

About Privia Health

Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 24 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 5.8+ million patients, and reward 5,300+ physicians and advanced practitioners for delivering high-value care.

Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com.

Contact
Robert Borchert
SVP, Investor & Corporate Communications
[email protected] 
817.783.4841


Risks

  • Financial results may not meet market expectations, impacting stock performance.
  • Healthcare regulatory changes could affect the company's operations or profitability.
  • Competitive pressures in healthcare services and technology could impact growth.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026